Inrig Jula sold TVTX
January 6, 2026 · Form 4 insider transaction
Inrig Jula sold 445 shares of Travere Therapeutics, Inc. at $37.75 per share, a transaction worth $16.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
445
Price
$37.75
Total value
$16.8K
InsiderInrig Jula
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 6, 2026
Filing dateJanuary 7, 2026
Shares owned after86,311
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.